comparemela.com

Latest Breaking News On - Mumbai coronavirus cases - Page 13 : comparemela.com

India reports 14,849 new COVID-19 cases, 155 more fatalities; recovery rate now 96 83%

Coronavirus News LIVE Updates: India s COVID-19 recovery rate now 96 58%, active cases remain below 3 lakh

News LATEST Updates:  Less than 50 per cent of the targeted beneficiaries turned up for coronavirus vaccination in Andhra Pradesh on the second day on Sunday, but that was the highest in the country.  According to data released by the Health Department, only 13,041 healthcare workers got the COVID-19 vaccine administered across the state against the targeted 27,233 for the day. The Union health ministry said that 2,07,229 people were vaccinated on day one- the highest day one vaccination number in the world. This figure is higher than the US, UK and France on day one, it said. The ministry s Additional Secretary ManohaAgnani also said a meeting was held with all states and Union Territories on Sunday to review the progress of the drive, identify bottlenecks and plan corrective actions.

Coronavirus News LIVE Updates: Bharat Biotech recruits 26,000 volunteers for Phase 3 COVAXIN trials which began November 2020

News LATEST Updates:   A dry run to assess the readiness of the mechanism laid out for the imminent COVID-19 immunisation drive will be undertaken in six sites of Uttar Pradesh from 5 January, the state government said on Sunday. In a statement, the government said the dry run will start at 10 am in three urban and as many rural sites with a minimum of two sessions Union health minister Harsh Vardhan said on Twitter that the approval for Covaxin was a monitored approval and it was a strategic decision for vaccine security. In another tweet, the health minister said that the emergency use authorisation for Covaxin is different from Covishield because the use of the former will be in clinical trial mode. All COVAXIN recipients to be tracked,monitored as if they’re in trial, he said.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.